查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621446

幹細胞市場：按類型、來源、應用和最終用戶分類 - 2025-2030 年全球預測

Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年幹細胞市值為136.6億美元，預計到2024年將達到150.5億美元，複合年成長率為10.79%，到2030年將達到279.9億美元。

幹細胞是未分化的生物細胞，可以分化成特化細胞並分裂產生更多的幹細胞。對幹細胞的需求源於它們在再生醫學方面的能力，為帕金森氏症、糖尿病和心臟病等多種疾病提供了治療潛力。其用途廣泛，包括醫療、藥物發現、研究和開發以及研究目的。調查目標包括醫院、診所、實驗室和生技公司。市場成長受到技術進步、研發投資增加以及需要先進醫療解決方案的慢性病盛行率上升的影響。有關幹細胞使用的市場開發法規和倫理問題可能對市場成長構成限制和挑戰。此外，幹細胞治療的高成本和該領域熟練專業人員的缺乏可能會阻礙市場擴張。然而，在擴大罕見疾病和遺傳性疾病的幹細胞研究和開發，以及探索與製藥公司建立合作夥伴關係以加強藥物開發過程方面，存在潛在的機會。創新努力可包括提高幹細胞移植的安全性和效率以及開發具有成本效益的生產方法。這個市場充滿活力，其特點是快速的技術進步和開創性治療方法的前景推動了投資者的強烈興趣。鼓勵企業專注於與學術機構和研究公司建立策略聯盟，以促進創新。此外，根據不斷變化的監管環境調整您的業務策略可以為您帶來競爭優勢。為了實現永續成長，公司還應優先透過透明度和投資教育大眾了解幹細胞治療的好處來解決道德問題。儘管競爭格局仍然充滿挑戰，但醫療應用和研究領域存在著成長和創新的機會。

主要市場統計
基準年[2023] 136.6億美元
預測年份 [2024] 150.5億美元
預測年份 [2030] 279.9億美元
複合年成長率（%） 10.79%

市場動態：揭示快速發展的幹細胞市場的關鍵市場洞察

供需的動態交互作用正在改變幹細胞市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 先進的基因組為基礎的細胞分析技術簡介
    • 增加對幹細胞療法開發的投資
    • 幹細胞庫和處理的基礎設施開發
  • 市場限制因素
    • 幹細胞治療高成本且缺乏相關技術人員
  • 市場機會
    • iPS 細胞治療應用的擴展以及利用幹細胞進行組織和器官再生的 3D 生物列印的進展
    • 擴大幹細胞在個人化醫療的應用
  • 市場挑戰
    • 胚胎幹細胞研究的倫理問題

波特五力：駕馭幹細胞市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解幹細胞市場的外部影響

外部宏觀環境因素在塑造幹細胞市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解幹細胞市場的競爭狀況

幹細胞市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣幹細胞市場供應商績效評估

FPNV定位矩陣是評估幹細胞市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議描繪幹細胞市場的成功之路

幹細胞市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 基於基因組的先進細胞分析技術介紹
      • 增加對幹細胞療法開發的投資
      • 與幹細胞儲存和處理相關的基礎設施開發
    • 抑制因素
      • 幹細胞治療成本高且缺乏熟練的人力資源
    • 機會
      • 擴大 iPSC 的治療應用以及使用幹細胞進行組織和器官再生的 3D 生物列印的進展
      • 擴大幹細胞在個人化醫療的應用
    • 任務
      • 胚胎幹細胞研究的倫理問題
  • 市場區隔分析
    • 類型：由於道德和監管障礙減少，成體幹細胞的使用正在增加
    • 應用：擴大幹細胞在診斷模型開發的應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章幹細胞市場：依類型

  • 成體幹細胞
  • 人類胚胎幹細胞
  • 誘導性多功能細胞

第7章 幹細胞市場：依來源分類

  • 同種異體的
  • 自體移植

第8章幹細胞市場：依應用分類

  • 診斷
  • 藥物發現與開發
  • 再生醫學
    • 心臟病學
    • 神經病學
    • 腫瘤學

第 9 章 幹細胞市場：依最終用戶分類

  • 學術研究所
  • 醫院和細胞庫
  • 製藥和生物技術公司

第10章美洲幹細胞市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區幹細胞市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲幹細胞市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • QHP Capital 收購 Applied StemCell
    • Stem Genomics 與 Pluristyx 合作提供多功能細胞產品和服務
    • denovoMATRIX 推出首款幹細胞產品，擴大產品系列
  • 戰略分析和建議

公司名單

  • Advanced Cell Technology, Inc.
  • AlloSource, Inc.
  • Anterogen Co., Ltd.
  • Athersys Inc.
  • Becton, Dickinson and Company
  • Bioheart Inc.
  • Biorestorative Therapies Inc.
  • BioTime, Inc.
  • BrainStorm Cell Therapeutics Inc.
  • Celgene Corporation
  • Cellartis AB
  • CellGenix GmbH
  • Cellular Engineering Technologies Inc.
  • Gamida Cell Ltd
  • GenScript Biotech Corporation
  • Gilead Sciences, Inc.
  • Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,
  • JCR Pharmaceuticals Co., Ltd.
  • Lonza Group Ltd
  • Novartis AG
  • NuVasive Inc.
  • Pluristyx, Inc.
  • RTI Surgical
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
Product Code: MRR-434CCDA04CF2

The Stem Cells Market was valued at USD 13.66 billion in 2023, expected to reach USD 15.05 billion in 2024, and is projected to grow at a CAGR of 10.79%, to USD 27.99 billion by 2030.

Stem cells are undifferentiated biological cells capable of differentiating into specialized cells and dividing to produce more stem cells. The necessity of stem cells stems from their capability in regenerative medicine, offering potential treatments for a range of medical conditions such as Parkinson's disease, diabetes, and heart diseases. Their application spans across medical therapies, drug discovery, and development, as well as research purposes. The end-use scope of stem cells includes hospitals, clinics, research centers, and biotechnology companies. Market growth is influenced by technological advancements, increased investments in research and development, and a rising prevalence of chronic diseases that require advanced medical solutions. Developing regulations and ethical concerns regarding stem cell use may pose limitations and challenges to market growth. Furthermore, the high cost of stem cell therapy and lack of skilled professionals in the field can hinder market expansion. Nonetheless, potential opportunities lie in expanding stem cell research and therapy applications to target rare diseases and genetic disorders, as well as exploring partnerships with pharmaceutical companies to enhance drug development processes. Innovations can focus on improving the safety and efficiency of stem cell transplants, and developing cost-effective production methods. The market is dynamic, marked by rapid technological advancement and a keen investor interest driven by the promise of pioneering treatments. Companies are encouraged to focus on strategic alliances with academic institutions and research firms to foster innovations. Additionally, aligning business strategies with evolving regulatory landscapes can provide a competitive advantage. For sustained growth, companies should also prioritize addressing ethical concerns through transparency and investing in educating the public about the benefits of stem cell therapies. The landscape remains competitive, yet rich with opportunities for growth and innovation in medical applications and research avenues.

KEY MARKET STATISTICS
Base Year [2023] USD 13.66 billion
Estimated Year [2024] USD 15.05 billion
Forecast Year [2030] USD 27.99 billion
CAGR (%) 10.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stem Cells Market

The Stem Cells Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Introduction of advanced Genome-based cell analysis techniques
    • Increasing investment in the development of stem cell therapies
    • Infrastructural development related to stem cell banking and processing
  • Market Restraints
    • High costs associated with stem cell therapies and lack of skilled personnel
  • Market Opportunities
    • Expansion of the therapeutic applications of iPSCs and advancements in 3D bioprinting using stem cells for tissue and organ regeneration
    • Growing applications of stem cells in personalized medicine
  • Market Challenges
    • Ethical issues surrounding embryonic stem cell research

Porter's Five Forces: A Strategic Tool for Navigating the Stem Cells Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stem Cells Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stem Cells Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stem Cells Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stem Cells Market

A detailed market share analysis in the Stem Cells Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stem Cells Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stem Cells Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stem Cells Market

A strategic analysis of the Stem Cells Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stem Cells Market, highlighting leading vendors and their innovative profiles. These include Advanced Cell Technology, Inc., AlloSource, Inc., Anterogen Co., Ltd., Athersys Inc., Becton, Dickinson and Company, Bioheart Inc., Biorestorative Therapies Inc., BioTime, Inc., BrainStorm Cell Therapeutics Inc., Celgene Corporation, Cellartis AB, CellGenix GmbH, Cellular Engineering Technologies Inc., Gamida Cell Ltd, GenScript Biotech Corporation, Gilead Sciences, Inc., Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,, JCR Pharmaceuticals Co., Ltd., Lonza Group Ltd, Novartis AG, NuVasive Inc., Pluristyx, Inc., RTI Surgical, Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Adult Stem Cell, Human Embryonic Stem Cell, and Induced Pluripotent Stem Cell.
  • Based on Source, market is studied across Allogenic and Autologous.
  • Based on Application, market is studied across Diagnostics, Drug Discovery & Development, and Regenerative Medicines. The Regenerative Medicines is further studied across Cardiology, Neurology, and Oncology.
  • Based on End-user, market is studied across Academic & Research Institutes, Hospitals & Cell Banks, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Introduction of advanced Genome-based cell analysis techniques
      • 5.1.1.2. Increasing investment in the development of stem cell therapies
      • 5.1.1.3. Infrastructural development related to stem cell banking and processing
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with stem cell therapies and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of the therapeutic applications of iPSCs and advancements in 3D bioprinting using stem cells for tissue and organ regeneration
      • 5.1.3.2. Growing applications of stem cells in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues surrounding embryonic stem cell research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing usage of adult stem cells due to its fewer ethical and regulatory hurdles
    • 5.2.2. Application: Expanding the application of stem cells in developing diagnostic models
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Stem Cells Market, by Type

  • 6.1. Introduction
  • 6.2. Adult Stem Cell
  • 6.3. Human Embryonic Stem Cell
  • 6.4. Induced Pluripotent Stem Cell

7. Stem Cells Market, by Source

  • 7.1. Introduction
  • 7.2. Allogenic
  • 7.3. Autologous

8. Stem Cells Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery & Development
  • 8.4. Regenerative Medicines
    • 8.4.1. Cardiology
    • 8.4.2. Neurology
    • 8.4.3. Oncology

9. Stem Cells Market, by End-user

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Cell Banks
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Stem Cells Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Stem Cells Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Stem Cells Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. QHP Capital Acquires Applied StemCell
    • 13.3.2. Stem Genomics, Pluristyx Partner for Pluripotent Stem Cell Products, Services
    • 13.3.3. denovoMATRIX Expands its Product Portfolio by Launching its First Stem Cell Product
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Cell Technology, Inc.
  • 2. AlloSource, Inc.
  • 3. Anterogen Co., Ltd.
  • 4. Athersys Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bioheart Inc.
  • 7. Biorestorative Therapies Inc.
  • 8. BioTime, Inc.
  • 9. BrainStorm Cell Therapeutics Inc.
  • 10. Celgene Corporation
  • 11. Cellartis AB
  • 12. CellGenix GmbH
  • 13. Cellular Engineering Technologies Inc.
  • 14. Gamida Cell Ltd
  • 15. GenScript Biotech Corporation
  • 16. Gilead Sciences, Inc.
  • 17. Holostem Terapie Avanzate Srl by Fondazione Enea Tech e Biomedical,
  • 18. JCR Pharmaceuticals Co., Ltd.
  • 19. Lonza Group Ltd
  • 20. Novartis AG
  • 21. NuVasive Inc.
  • 22. Pluristyx, Inc.
  • 23. RTI Surgical
  • 24. Takeda Pharmaceutical Company Limited
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. STEM CELLS MARKET RESEARCH PROCESS
  • FIGURE 2. STEM CELLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STEM CELLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STEM CELLS MARKET DYNAMICS
  • TABLE 7. GLOBAL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STEM CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STEM CELLS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STEM CELLS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STEM CELLS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL STEM CELLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES STEM CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM STEM CELLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM STEM CELLS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM STEM CELLS MARKET SIZE, BY REGENERATIVE MEDICINES, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM STEM CELLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023